Archive
Proactive news snapshot: Amryt Pharma, Directa Plus, Live Company...
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 8 of 15
Allergy Therapeutics pleased with the current momentum in the business
"We look forward to the exciting developments in our early pipeline planned for 2019, and we expect to continue to grow our European business while progressing towards US and German registration for our lead products," said company chairman
Investments and investor services
FTSE 100 closes near flat as traders sit on hands ahead of Fed
The UK blue-chip index closed nearly four points higher at 7,511
Archive
Expected US interest rate hike to draw the attention Wednesday, as Trump trade wars rumble on
Aside from the US interest rate decision, corporate updates are due from online fashion retailer Boohoo Group, outsourcer MITIE, and automotive services firm The AA ...
Archive
US interest rate hike eyed, as retailers, tour operators and utilities provide updates in coming week
Aside from the latest Federal Reserve policy meeting, the week ahead will bring updates from the likes of Next, Thomas Cook, TUI, United Utilities, and Pennon
Archive
Proactive news snapshot: dotdigital Group, Live Company Group, ECR Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Everyman's plans to open a cinema in the heart of the City welcomed by the City
Companies featured today: Babcock, Be Heard, dotdigital, Everyman, Goals Soccer Centres and Sopheon
Allergy Therapeutics raises £10.6mln to fund expansion of late-stage PQ Grass study
As well as funding the late-stage PQ Grass trial, the cash will also be used to part-fund the phase II study of Acarovac, the company’s dust mite allergy treatment
Investments and investor services
FTSE 100 closes marginally higher but European peers and US stocks lag
Footsie closed up around seven points, or 0.10% at 7,683 on Thursday
Bellzone knocks out £1mln placing after recent share price surge
Some of the main news-driven risers and fallers in London on Thursday ...
Archive
Proactive news snapshot: AFC Energy, ADES International, Europa Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics full-year revenues to rise once again despite “unusually weak” pollen season
The allergy vaccines maker expects to report a 6.6% rise in revenues for the year ended June 30
FTSE 100 closes higher Thursday as traders come back to equities
Sterling was also stronger - up 0.06% to 1.1318 against the Euro and up 0.12% versus the US dollar
Archive
Proactive news snapshot: Greatland Gold, 88 Energy, MySQUAR, Galantas Gold …
A glance at some of the day's highlights from the Proactive Investors newswire
Edenville Energy shares up as it extends MoU with Chinese contractor for Rukwa project
A look at some of the top risers and fallers in London today
Allergy Therapeutics announces publication of positive data of Pollinex Quattro Grass vaccines
The company said each of the clinical symptoms (runny nose, sneezing and conjunctivitis) were statistically significantly reduced in treated patients compared with controls without allergen-specific immunotherapy
FTSE 100 crashes 2.26% as traders shun risk
FTSE 100 tanked on the day, along with other European indices
Archive
Proactive news snapshot: ImmuPharma, Advanced Oncotherapy, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
88 Energy surges after confirming it on track to restart well-testing at Icewine-2
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
Allergy Therapeutics announces positive new clinic data with house-dust mite immunotherapy
The AIM-listed biotechnology company said the total of 141 patients were evaluated and they demonstrated a 43% decrease in combined symptom medication score compared with baseline after one year